OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Wave Life Sciences

1 Projects | 1 Researchers | $1,190,392 Invested

2021

Wave Life Sciences

Anne-Marie Li-Kwai-Cheung

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

  • Funding Amount: $1,190,392
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Proteostasis
  • Status: Closed